Results of a phase II trial of a combination of oral cytarabine ocfosfate (YNK01) and interferon alpha-2b for the treatment of chronic myelogenous leukemia patients in chronic phase.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples